Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siam Hibiscus is a Thailand-based company specializing in the extraction and standardization of bioactive compounds from Hibiscus sabdariffa (Roselle). The company operates within the natural products and nutraceutical sector, providing high-purity extracts rich in anthocyanins and polyphenols for use in health-promoting formulations. Their business model focuses on the industrial-scale production of botanical ingredients that target cardiovascular health and metabolic wellness. Siam Hibiscus is a significant player in the Southeast Asian herbal export market, maintaining quality standards suitable for international pharmaceutical and food-grade applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Siam Hibiscus.